ReShape Lifesciences Inc. (NASDAQ:RSLS – Get Free Report) was the recipient of a large decline in short interest in April. As of April 15th, there was short interest totalling 487,800 shares, a decline of 33.1% from the March 31st total of 729,300 shares. Based on an average daily volume of 520,900 shares, the short-interest ratio […]
ReShape Lifesciences (NASDAQ:RSLS – Get Free Report) and Vivos Therapeutics (NASDAQ:VVOS – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk. Profitability This table compares ReShape Lifesciences and […]
By Denny Jacob ReShape Lifesciences shares rose 5.6% to 33 cents in premarket trading following news that it is looking to identify potential strategic.
By Ben Glickman ReShape Lifesciences said Tuesday its modified treatment for obesity had received approval from the Food and Drug Administration. The company.
By Denny Jacob ReShape Lifesciences received approval for a PMA supplement for its Lap-Band 2.0 FLEX from the Food and Drug Administration. The approval is.